228 related articles for article (PubMed ID: 24618007)
1. Hydroxysafflor yellow A suppresses liver fibrosis induced by carbon tetrachloride with high-fat diet by regulating PPAR-γ/p38 MAPK signaling.
Liu Q; Wang CY; Liu Z; Ma XS; He YH; Chen SS; Bai XY
Pharm Biol; 2014 Sep; 52(9):1085-93. PubMed ID: 24618007
[TBL] [Abstract][Full Text] [Related]
2. Hydroxysafflor yellow A protects against chronic carbon tetrachloride-induced liver fibrosis.
Zhang Y; Guo J; Dong H; Zhao X; Zhou L; Li X; Liu J; Niu Y
Eur J Pharmacol; 2011 Jun; 660(2-3):438-44. PubMed ID: 21536026
[TBL] [Abstract][Full Text] [Related]
3. Activation of PPARγ is required for hydroxysafflor yellow A of Carthamus tinctorius to attenuate hepatic fibrosis induced by oxidative stress.
Wang CY; Liu Q; Huang QX; Liu JT; He YH; Lu JJ; Bai XY
Phytomedicine; 2013 May; 20(7):592-9. PubMed ID: 23523101
[TBL] [Abstract][Full Text] [Related]
4. Hydroxysafflor yellow A attenuates carbon tetrachloride-induced hepatic fibrosis in rats by inhibiting ERK5 signaling.
Zhang YB; Dong HY; Zhao XM; Fan L; Zou Y; Zhang C; Li G; Liu JC; Niu YC
Am J Chin Med; 2012; 40(3):481-94. PubMed ID: 22745065
[TBL] [Abstract][Full Text] [Related]
5. Hydroxysafflor yellow A of Carthamus tinctorius attenuates lung injury of aged rats exposed to gasoline engine exhaust by down-regulating platelet activation.
Wang C; Wang C; Ma C; Huang Q; Sun H; Zhang X; Bai X
Phytomedicine; 2014 Feb; 21(3):199-206. PubMed ID: 24192212
[TBL] [Abstract][Full Text] [Related]
6. Restorative effects of hydroxysafflor yellow A on hepatic function in an experimental regression model of hepatic fibrosis induced by carbon tetrachloride.
Li Y; Shi Y; Sun Y; Liu L; Bai X; Wang D; Li H
Mol Med Rep; 2017 Jan; 15(1):47-56. PubMed ID: 27909717
[TBL] [Abstract][Full Text] [Related]
7. Hydroxysafflor yellow A induces apoptosis in activated hepatic stellate cells through ERK1/2 pathway in vitro.
Li CC; Yang CZ; Li XM; Zhao XM; Zou Y; Fan L; Zhou L; Liu JC; Niu YC
Eur J Pharm Sci; 2012 Aug; 46(5):397-404. PubMed ID: 22449726
[TBL] [Abstract][Full Text] [Related]
8. Hydroxysafflor Yellow A Ameliorates Renal Fibrosis by Suppressing TGF-β1-Induced Epithelial-to-Mesenchymal Transition.
Hu N; Duan J; Li H; Wang Y; Wang F; Chu J; Sun J; Liu M; Wang C; Lu C; Wen A
PLoS One; 2016; 11(4):e0153409. PubMed ID: 27088510
[TBL] [Abstract][Full Text] [Related]
9. Hydroxysafflor yellow A inhibits TGF-β1-induced activation of human fetal lung fibroblasts in vitro.
Pan R; Zhang Y; Zang B; Tan L; Jin M
J Pharm Pharmacol; 2016 Oct; 68(10):1320-30. PubMed ID: 27457091
[TBL] [Abstract][Full Text] [Related]
10. Hydroxysafflor yellow A inhibits the proliferation, migration, and invasion of colorectal cancer cells through the PPARγ/PTEN/Akt signaling pathway.
Su D; Lv C
Bioengineered; 2021 Dec; 12(2):11533-11543. PubMed ID: 34889713
[TBL] [Abstract][Full Text] [Related]
11. Hydroxysafflor Yellow A Attenuates Bleomycin-induced Pulmonary Fibrosis in Mice.
Jin M; Wu Y; Wang L; Zang B; Tan L
Phytother Res; 2016 Apr; 30(4):577-87. PubMed ID: 26777519
[TBL] [Abstract][Full Text] [Related]
12. Protective Effect of Hydroxysafflor Yellow A on Inflammatory Injury in Chronic Obstructive Pulmonary Disease Rats.
Jin M; Xue CJ; Wang Y; Dong F; Peng YY; Zhang YD; Zang BX; Tan L
Chin J Integr Med; 2019 Oct; 25(10):750-756. PubMed ID: 30588579
[TBL] [Abstract][Full Text] [Related]
13. Hydroxysafflor yellow A suppresses inflammatory responses of BV2 microglia after oxygen-glucose deprivation.
Li J; Zhang S; Lu M; Chen Z; Chen C; Han L; Zhang M; Xu Y
Neurosci Lett; 2013 Feb; 535():51-6. PubMed ID: 23333598
[TBL] [Abstract][Full Text] [Related]
14. The ability of hydroxysafflor yellow a to attenuate lipopolysaccharide-induced pulmonary inflammatory injury in mice.
Sun CY; Pei CQ; Zang BX; Wang L; Jin M
Phytother Res; 2010 Dec; 24(12):1788-95. PubMed ID: 20564507
[TBL] [Abstract][Full Text] [Related]
15. Hydroxysafflor yellow A suppresses angiogenesis of hepatocellular carcinoma through inhibition of p38 MAPK phosphorylation.
Zhang J; Li J; Song H; Xiong Y; Liu D; Bai X
Biomed Pharmacother; 2019 Jan; 109():806-814. PubMed ID: 30551534
[TBL] [Abstract][Full Text] [Related]
16. Hydroxysafflor yellow A attenuates ischemia/reperfusion-induced liver injury by suppressing macrophage activation.
Jiang S; Shi Z; Li C; Ma C; Bai X; Wang C
Int J Clin Exp Pathol; 2014; 7(5):2595-608. PubMed ID: 24966974
[TBL] [Abstract][Full Text] [Related]
17. A PPAR-Gamma Agonist Rosiglitazone Suppresses Fibrotic Response in Human Pterygium Fibroblasts by Modulating the p38 MAPK Pathway.
Nuwormegbe SA; Sohn JH; Kim SW
Invest Ophthalmol Vis Sci; 2017 Oct; 58(12):5217-5226. PubMed ID: 29049722
[TBL] [Abstract][Full Text] [Related]
18. Protective effects of hydroxysafflor yellow A (HSYA) on alcohol-induced liver injury in rats.
He Y; Liu Q; Li Y; Yang X; Wang W; Li T; Zhang W; Cui Y; Wang C; Lin R
J Physiol Biochem; 2015 Mar; 71(1):69-78. PubMed ID: 25626885
[TBL] [Abstract][Full Text] [Related]
19. Hydroxysafflor yellow A ameliorates lipopolysaccharide-induced acute lung injury in mice via modulating toll-like receptor 4 signaling pathways.
Liu YL; Liu YJ; Liu Y; Li XS; Liu SH; Pan YG; Zhang J; Liu Q; Hao YY
Int Immunopharmacol; 2014 Dec; 23(2):649-57. PubMed ID: 25466274
[TBL] [Abstract][Full Text] [Related]
20. Hydroxysafflor yellow A exerts neuroprotective effects in cerebral ischemia reperfusion-injured mice by suppressing the innate immune TLR4-inducing pathway.
Lv Y; Qian Y; Fu L; Chen X; Zhong H; Wei X
Eur J Pharmacol; 2015 Dec; 769():324-32. PubMed ID: 26607471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
